Keytruda may be a miracle cancer drug but big questions are being asked about affordability to the people who need it most

Information improves our Outcomes
What do you think about this article ? can you add? do you know of other articles on this subject?

can those who need it afford it?

Keytruda (generic name pembrolizumab) is an immunotherapy drug manufactured by the company Merck & Co. It is most commonly used to treat melanoma, and was listed for this use by Australia’s Therapeutic Goods Administration in April 2015.

In March 2017, the TGA extended approval for Keytruda to treat a specific type of lung cancer called non small-cell lung carcinoma. In the same month it was approved by the US Food and Drug Administration (FDA) for classical Hodgkin lymphoma, and the TGA later also approved it for this condition.

To continue reading see Original Article @
The fourth pillar: how we’re arming the immune system to help fight cancer

Article discovered via